The purpose of this study is to compare health-related costs and asthma control in ordinary clinical practice during 12 months for Symbicort® given as a low maintenance dose plus as needed compared to a free combination of Pulmicortâ and Oxis® plus Bricanyl® as needed, and Symbicort fixed dosing plus Bricanyl as needed in asthmatic patients not adequately controlled on inhaled glucocorticosteroids alone.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
1,970
Asthma-related health-care utilization as measured by total amount of asthma medication purchased and number of contacts with health-care facilities
Number of days patients or assistant persons are absent from work due to patient's asthma
Number of exacerbations and treatment failures
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Research Site
Alingsås, Sweden
Research Site
Angered, Sweden
Research Site
Arlöv, Sweden
Research Site
Arvidsjaur, Sweden
Research Site
Arvika, Sweden
Research Site
Ängelholm, Sweden
Research Site
Åkersberga, Sweden
Research Site
Ånge, Sweden
Research Site
Årsta, Sweden
Research Site
Åstorp, Sweden
...and 98 more locations